Solution
Industries
Resources
About

Ubiquitin Proteasome Drugs: Cancer and Neurodegenerative Disorder Markets

Report Code: PHM066A

Publish Date: Jul 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • There is only one approved UPS product on the market, Velcade, a proteasome inhibitor, with total sales of more than $1.4 billion in 2009. This drug is expected to be worth $3 billion in 2015, a compound annual growth rate (CAGR) of 13.5% over the study period.
  • In the U.S., Velcade was worth $468 million in 2009 and is expected to reach $1 billion in 2015, a compound annual growth rate (CAGR) of 13.5%. 
  • Worldwide, Velcade was valued at $933 million in 2009 and is expected to reach $2 billion by 2015, a compound annual growth rate (CAGR) of 13.6%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC Research report, Ubiquitin Proteasome Drug Discovery: Cancer and Neurodegenerative Markets, provides an overview of the current state of drug discovery in the ubiquitin proteasome research field, existing products on the market, and detailed analysis of the competitive environments, including new potential markets for current research projects. The study includes information about significant players in this field of study, trends, and challenges, and other information affecting drug discovery in the ubiquitin proteasome system (UPS).

REASONS FOR DOING THIS STUDY
 
The scientists who discovered the UPS were awarded the Nobel Prize in Chemistry in 2004. UPS represents one of the most-studied and challenging areas in basic and applicable science. Since 2004, ubiquitin ligases and proteasome function have become one of the major targets for pharmaceutical and drug development companies.
 
Yet, despite the accumulation of basic knowledge about the mechanism of action of this cellular phenomenon, progress in drug screening and therapeutic development has been delayed. However, the proven success of the proteasome inhibitor bortezomib in addition to a recent breakthrough in the identification of new drug candidates in the UPS research field bring new excitement and hope for further successful drug development. More importantly, the real commercial potential of this research area has not yet been fully acknowledged.
 
This study will provide knowledge of the current state of drug discovery in this field and new technologies in assay development, and, more importantly, will describe potential novel commercial venues in this drug discovery.
 
SCOPE OF REPORT
 
This subject is relatively new to the market research report format and provides business tools to evaluate new commercial opportunities in the drug discovery field. The geographic scope of this study covers U.S. and global companies. The report identifies two major research trends in UPS: proteasome inhibitors versus ubiquitination reaction components as drug targets. This study describes current products in each area, identifies current market participants and, most importantly, notes the trends that are going to affect further drug development in this area. The report also provides information about less-developed areas of UPS, and gives a list of current companies that have new UPS-related products in development.
 
METHODOLOGY AND INFORMATION SOURCES
 
The research methodology used in this report has been qualitative in nature and has employed a triangulating approach, which aids in validity. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already-marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis were also conducted.
 
In a second phase, a series of semistructured interviews were conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotech and pharmaceutical companies. Other resources included academics, technology, and consulting companies. These were rich sources of data. Subsequent analysis of the documents and interview notes was iterative.
 
INTENDED AUDIENCE
 
This report is intended for business development professionals, entrepreneurs, and other investment groups so that they can fully understand and evaluate a new, less-familiar area of drug discovery and development. It provides companies’ corporate development departments new insight into competitors’ positions and shows new opportunities otherwise overlooked or less known to the public.
 
ANALYST CREDENTIALS
 
Dr. Marianna Tcherpakov has more than 7 years’ experience as a bench scientist specializing in the area of UPS research. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with this research field’s trends and likely future developments.
 
BCC ONLINE SERVICES

BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:

  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Ubiquitin Proteasome Drugs: Cancer and Neurodegenerative Disorder Markets146Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW OF SCIENTIFIC BACKGROUND,AND SIGNIFICANCE OF UPS RESEARCH 7Free
Chapter- 4: MAJOR DRUG DEVELOPMENT AND PRODUCTSIN THE UPS RESEARCH FIELD 65Free
Chapter- 5: DUB AS A TARGET FOR DRUG DISCOVERY8Free
Chapter- 6: UBIQUITIN-LIKE MODIFIERS AS TARGETS FOR DRUG DISCOVERY14Free
Chapter- 7: SCIENTIFIC/TECHNOLOGICAL BREAKTHROUGHS IN UPS23Free
Chapter- 8: MARKET SUMMARY5Free
Chapter- 9: SELECT COMPANY OVERVIEW11Free
Chapter- 10: DIRECTORY OF COMPANIES7Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 70

  • Summary Table: U.S. AND WORLDWIDE NET SALES OF VELCADE, THROUGH 2015
  • Table 1: ENZYMATIC COMPONENTS OF UBIQTUINATION/DEUBIQUITINATION REACTION
  • Table 2: UBLS, THEIR FUNCTION AND ASSOCIATED PATHOLOGY WITH THEIR DYSFUNCTION
  • Table 3: U.S. STATISTICS FOR HEMATOLOGICAL MALIGNANCIES, 2009
  • Table 4: PROJECTED SIZE OF THE WORLDWIDE MM DRUG MARKET,2009 AND 2018
  • Table 5: U.S. AND WORLDWIDE NET SALES OF VELCADE, THROUGH 2015
  • Table 6: WORLDWIDE NET SALES OF REVLIMID AND THALOMID, THROUGH 2016
  • Table 7: WORLDWIDE SHARES OF THE MM TREATMENT MARKET: MILLENNIUM/TAKEDA, CELGENE, AND OTHER DRUG COMPANY SHARES IN 2009 COMPARED TO THOSE PROJECTED IN 2011*
  • Table 8: EXAMPLE OF COSTS OF SIDE EFFECTS OF CHEMOTHERAPY TREATMENT PER PATIENT IN THE U.S., 2006
  • Table 9: CURRENT R&D ACTIVITY IN UPS BY MILLENNIUM/TAKEDA
  • Table 10: COMPANIES WITH CURRENT R&D IN PROTEASOME INHIBITION AS A DRUG TARGET
Sample Report

Recent Reports

Clinical Nutrition: Global Markets to 2031

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM198C

The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.

Substance Use Disorder Treatment: Global Markets to 2030

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM035D

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - PHM017H

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

Cardiovascular Drugs: Global Markets to 2030

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM191B

The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.

Emerging Drugs: Global Markets

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM291A

The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Ubiquitin Proteasome Drugs: Cancer and Neurodegenerative Disorder Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment